Cargando…
APOE E4 is associated with hyperlipidemia and obesity in elderly schizophrenic patients
Obesity is a critical issue in patients with schizophrenia, which is considered to be brought about by both environmental and genetic factors. Apolipoprotein E (APOE) gene polymorphisms might be involved in the pathogenesis of schizophrenia, however, the effect of APOE gene polymorphism on obesity h...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292406/ https://www.ncbi.nlm.nih.gov/pubmed/34285334 http://dx.doi.org/10.1038/s41598-021-94381-4 |
_version_ | 1783724826412711936 |
---|---|
author | Li, Wei Liu, Fengju Liu, Rui Zhou, Xinmei Li, Guanjun Xiao, Shifu |
author_facet | Li, Wei Liu, Fengju Liu, Rui Zhou, Xinmei Li, Guanjun Xiao, Shifu |
author_sort | Li, Wei |
collection | PubMed |
description | Obesity is a critical issue in patients with schizophrenia, which is considered to be brought about by both environmental and genetic factors. Apolipoprotein E (APOE) gene polymorphisms might be involved in the pathogenesis of schizophrenia, however, the effect of APOE gene polymorphism on obesity has never been investigated in Chinese aging with schizophrenia. This cross-sectional study was to investigate the effect of obesity on cognitive and psychiatric symptoms in elderly participants with schizophrenia. At the same time, we also discussed the inner link between APOE E4 and obesity. 301 elderly participants with schizophrenia and 156 normal controls were included in the study. Their cognitive function was assessed using the Montreal Cognitive Assessment (MoCA), psychiatric symptoms were assessed using the Positive and Negative Syndrome Scale (PANSS), and APOE gene polymorphism was determined by polymerase chain reaction (PCR). The prevalence of obesity in elderly schizophrenic patients and healthy controls accounted for 15.9% (48/301) and 10.3% (16/156), respectively, with no statistically significant difference. By using stepwise linear regression analysis, we found that elevated fasting blood glucose, hypertension, and hyperlipidemia were risk factors for obesity in elderly schizophrenic patients. Although there was no direct correlation between APOE E4 and obesity in patients with schizophrenia, it was significantly correlated with hyperlipemia(r = − 0.154, p = 0.008), suggesting that APOE E4 may induce obesity in elderly patients with schizophrenia through hyperlipemia, However, the above conclusions do not apply to the normal elderly. What’s more, we did not find a link between obesity and cognitive function or mental symptoms for both patients with schizophrenia and normal controls. APOE E4 is associated with hyperlipidemia in elderly schizophrenic patients, which may be a risk factor for obesity, however, the above conclusion does not apply to the normal elderly. |
format | Online Article Text |
id | pubmed-8292406 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-82924062021-07-22 APOE E4 is associated with hyperlipidemia and obesity in elderly schizophrenic patients Li, Wei Liu, Fengju Liu, Rui Zhou, Xinmei Li, Guanjun Xiao, Shifu Sci Rep Article Obesity is a critical issue in patients with schizophrenia, which is considered to be brought about by both environmental and genetic factors. Apolipoprotein E (APOE) gene polymorphisms might be involved in the pathogenesis of schizophrenia, however, the effect of APOE gene polymorphism on obesity has never been investigated in Chinese aging with schizophrenia. This cross-sectional study was to investigate the effect of obesity on cognitive and psychiatric symptoms in elderly participants with schizophrenia. At the same time, we also discussed the inner link between APOE E4 and obesity. 301 elderly participants with schizophrenia and 156 normal controls were included in the study. Their cognitive function was assessed using the Montreal Cognitive Assessment (MoCA), psychiatric symptoms were assessed using the Positive and Negative Syndrome Scale (PANSS), and APOE gene polymorphism was determined by polymerase chain reaction (PCR). The prevalence of obesity in elderly schizophrenic patients and healthy controls accounted for 15.9% (48/301) and 10.3% (16/156), respectively, with no statistically significant difference. By using stepwise linear regression analysis, we found that elevated fasting blood glucose, hypertension, and hyperlipidemia were risk factors for obesity in elderly schizophrenic patients. Although there was no direct correlation between APOE E4 and obesity in patients with schizophrenia, it was significantly correlated with hyperlipemia(r = − 0.154, p = 0.008), suggesting that APOE E4 may induce obesity in elderly patients with schizophrenia through hyperlipemia, However, the above conclusions do not apply to the normal elderly. What’s more, we did not find a link between obesity and cognitive function or mental symptoms for both patients with schizophrenia and normal controls. APOE E4 is associated with hyperlipidemia in elderly schizophrenic patients, which may be a risk factor for obesity, however, the above conclusion does not apply to the normal elderly. Nature Publishing Group UK 2021-07-20 /pmc/articles/PMC8292406/ /pubmed/34285334 http://dx.doi.org/10.1038/s41598-021-94381-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Li, Wei Liu, Fengju Liu, Rui Zhou, Xinmei Li, Guanjun Xiao, Shifu APOE E4 is associated with hyperlipidemia and obesity in elderly schizophrenic patients |
title | APOE E4 is associated with hyperlipidemia and obesity in elderly schizophrenic patients |
title_full | APOE E4 is associated with hyperlipidemia and obesity in elderly schizophrenic patients |
title_fullStr | APOE E4 is associated with hyperlipidemia and obesity in elderly schizophrenic patients |
title_full_unstemmed | APOE E4 is associated with hyperlipidemia and obesity in elderly schizophrenic patients |
title_short | APOE E4 is associated with hyperlipidemia and obesity in elderly schizophrenic patients |
title_sort | apoe e4 is associated with hyperlipidemia and obesity in elderly schizophrenic patients |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292406/ https://www.ncbi.nlm.nih.gov/pubmed/34285334 http://dx.doi.org/10.1038/s41598-021-94381-4 |
work_keys_str_mv | AT liwei apoee4isassociatedwithhyperlipidemiaandobesityinelderlyschizophrenicpatients AT liufengju apoee4isassociatedwithhyperlipidemiaandobesityinelderlyschizophrenicpatients AT liurui apoee4isassociatedwithhyperlipidemiaandobesityinelderlyschizophrenicpatients AT zhouxinmei apoee4isassociatedwithhyperlipidemiaandobesityinelderlyschizophrenicpatients AT liguanjun apoee4isassociatedwithhyperlipidemiaandobesityinelderlyschizophrenicpatients AT xiaoshifu apoee4isassociatedwithhyperlipidemiaandobesityinelderlyschizophrenicpatients |